Sarcoidosis News and Research

Latest Sarcoidosis News and Research

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

Elevated rates of 'Sarcoid Like' Granulomatous Pulmonary Disease found in WTC responders

Chest: January news briefs

Chest: January news briefs

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Twelve residents receive one-year fellowship grant to study medical dermatology

Twelve residents receive one-year fellowship grant to study medical dermatology

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

National Cancer Institute grants $9.1M award to BUSM

National Cancer Institute grants $9.1M award to BUSM

Chronic pediatric cough linked to reflux and allergies

Chronic pediatric cough linked to reflux and allergies

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191